Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.

作者: P E Lonning , S I Helle , S Lundgren

DOI:

关键词: Megestrol acetateInternal medicineDehydroepiandrosterone sulfateEstrogenEstroneAromataseMedicineEndocrinologyEstrone sulfateTestosteroneMegestrol

摘要: Twelve postmenopausal women suffering from advanced breast cancer had plasma estrogens, androgens, cortisol, and gonadotropins determined before therapy during treatment with megestrol acetate (MA) in oral doses escalated 40 to 160 mg. The clearance production rate of estrone sulfate were after 4 weeks mg MA. Treatment MA suppressed levels dehydroepiandrosterone sulfate, androstenedione, cortisol a dose-dependent manner <10% pretreatment values. Plasma testosterone, estradiol, estrone, 18-29% values, whereas the 35-52%. rates increased by mean value 23.7% (P < 0.01) 23.5% 0.025), reduced 76.7% 0.0005) 76.1% 0.0005), respectively. Our findings indicate that causes profound suppression adrenal steroid but addition suppresses ovarian secretion androgens patients. reduction estrogens is comparable values obtained commonly used aromatase inhibitors may be responsible for its antitumor effects cancer.

参考文章(47)
Steven J. Santner, Donald Leszczynski, Carol Wright, Andrea Manni, Peter D. Feil, Richard J. Santen, Estrone sulfate: a potential source of estradiol in human breast cancer tissues. Breast Cancer Research and Treatment. ,vol. 7, pp. 35- 44 ,(1986) , 10.1007/BF01886734
H. van Veelen, P. H. B. Willemse, D. T. Sleijfer, E. van der Ploeg, W. J. Sluiter, H. Doorenbos, MECHANISM OF ADRENAL SUPPRESSION BY HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS Cancer Chemotherapy and Pharmacology. ,vol. 15, pp. 167- 170 ,(1985) , 10.1007/BF00257530
M. Reed, P. Beranek, S. Franks, V. H. T. James, The effect of glucocorticoids on the in vivo conversion of androstenedione to oestrone. Hormone and Metabolic Research. ,vol. 18, pp. 635- 637 ,(1986) , 10.1055/S-2007-1012392
A V Sluijmer, M J Heineman, F H De Jong, J L Evers, Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. The Journal of Clinical Endocrinology and Metabolism. ,vol. 80, pp. 2163- 2167 ,(1995) , 10.1210/JCEM.80.7.7608272
R.F. Pommier, E.A. Woltering, W.S. Fletcher, Changes in serum sex steroid levels during megestrol acetate therapy Surgical Oncology-oxford. ,vol. 3, pp. 351- 359 ,(1994) , 10.1016/0960-7404(94)90074-4
A. VERMEULEN, The Hormonal Activity of the Postmenopausal Ovary The Journal of Clinical Endocrinology and Metabolism. ,vol. 42, pp. 247- 253 ,(1976) , 10.1210/JCEM-42-2-247
Pierre Alberto, Bernadette Mermillod, Eli Kaplan, Aron Goldhirsch, Jean-Pierre Obrecht, Felix Jungi, Georg Martz, Laurent Barrelet, Franco Cavalli, A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: Low response in patients previously treated with medroxyprogesterone European Journal of Cancer and Clinical Oncology. ,vol. 21, pp. 423- 428 ,(1985) , 10.1016/0277-5379(85)90031-8